TC Biopharm (Holdings) Plc
TCBPY
$0.4898
$0.219881.41%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -14.57M | -10.82M | -7.38M | -4.56M | -1.68M |
| Total Depreciation and Amortization | 789.50K | 838.30K | 896.90K | 932.90K | 965.00K |
| Total Amortization of Deferred Charges | 3.70K | 3.70K | 3.70K | 6.10K | 8.40K |
| Total Other Non-Cash Items | 2.61M | -3.32M | -7.69M | -8.61M | -9.54M |
| Change in Net Operating Assets | -347.80K | 304.60K | 697.40K | -2.52M | -5.75M |
| Cash from Operations | -11.51M | -12.99M | -13.47M | -14.75M | -15.99M |
| Capital Expenditure | 34.50K | 12.40K | -133.50K | -300.00K | -467.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 32.30K | 64.70K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -69.40K | -99.00K | -122.30K | -127.40K | -132.00K |
| Cash from Investing | -34.90K | -86.60K | -255.90K | -395.20K | -534.90K |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | 178.20K | 178.20K | 178.20K | 10.30K | -157.60K |
| Issuance of Common Stock | 7.54M | 4.76M | 5.19M | 3.54M | 1.90M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 523.60K | 743.40K | 3.33M | 5.63M | 7.92M |
| Cash from Financing | 10.37M | 7.13M | 10.75M | 11.16M | 11.53M |
| Foreign Exchange rate Adjustments | 8.70K | 8.70K | 8.70K | -23.20K | -55.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.17M | -5.94M | -2.97M | -4.00M | -5.05M |